Open AccessUse of low dose of rFVIIa (recombinant Factor VII activated) to control late bleeding after percutaneous dilational tracheostomy
Author(s) -
Nicosia Dario,
Federico Antonino,
Vigna Ivan,
Iozzo Pasquale,
Misseri Giovanni,
Cortegiani Andrea
Publication year - 2019
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.2061
Subject(s) - medicine , bolus (digestion) , anesthesia , intravenous bolus , recombinant factor viia , percutaneous , surgery , recombinant dna , factor viia , coagulation , biochemistry , chemistry , tissue factor , gene
Key Clinical Message In our case, the use of a low intravenous bolus dose of rFVIIa (recombinant factor VII activated; 15‐20 mcg/kg) was effective and uneventful in controlling late postprocedural PDT bleeding associated with thrombocytopenia that cannot be corrected and after all other treatments failed.